Kwality [KPL] vs Innova Captab [INNOVACAP] Detailed Stock Comparison

Kwality Pharmaceuticals Ltd.

BSE
Loading...

Innova Captab Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Kwality Pharmaceuticals Ltd. wins in 13 metrics, Innova Captab Ltd. wins in 6 metrics, with 0 ties. Kwality Pharmaceuticals Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Kwality Pharmaceuticals Ltd. Innova Captab Ltd. Better
P/E Ratio (TTM) 30.86 31.20 Kwality Pharmaceuticals Ltd.
Price-to-Book Ratio 6.02 4.05 Innova Captab Ltd.
Debt-to-Equity Ratio 38.29 32.95 Innova Captab Ltd.
PEG Ratio 0.35 1.33 Kwality Pharmaceuticals Ltd.
EV/EBITDA 17.28 20.49 Kwality Pharmaceuticals Ltd.
Profit Margin (TTM) 12.25% 8.85% Kwality Pharmaceuticals Ltd.
Operating Margin (TTM) 20.79% 12.88% Kwality Pharmaceuticals Ltd.
EBITDA Margin (TTM) 20.79% 12.88% Kwality Pharmaceuticals Ltd.
Return on Equity 15.19% 13.37% Kwality Pharmaceuticals Ltd.
Return on Assets (TTM) 8.91% 8.12% Kwality Pharmaceuticals Ltd.
Free Cash Flow (TTM) $277.15M $-1.09B Kwality Pharmaceuticals Ltd.
Dividend Yield N/A 0.30% N/A
1-Year Return 159.49% -3.19% Kwality Pharmaceuticals Ltd.
Price-to-Sales Ratio (TTM) 3.78 2.76 Innova Captab Ltd.
Enterprise Value $18.21B $43.41B Innova Captab Ltd.
EV/Revenue Ratio 3.95 2.90 Innova Captab Ltd.
Gross Profit Margin (TTM) 52.12% 35.19% Kwality Pharmaceuticals Ltd.
Revenue per Share (TTM) $444 $262 Kwality Pharmaceuticals Ltd.
Earnings per Share (Diluted) $54.54 $23.16 Kwality Pharmaceuticals Ltd.
Beta (Stock Volatility) 0.13 -0.33 Innova Captab Ltd.

Kwality Pharmaceuticals Ltd. vs Innova Captab Ltd. Stock Performance Analysis

Loading Price Chart...

KPL
INNOVACAP

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Kwality Pharmaceuticals Ltd.2.22%6.00%38.44%51.48%148.86%103.68%
Innova Captab Ltd.-0.63%2.24%2.13%29.82%21.15%16.79%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Kwality Pharmaceuticals Ltd.159.49%686.37%2,110.86%10,168.22%10,168.22%10,168.22%
Innova Captab Ltd.-3.19%57.07%57.07%57.07%57.07%57.07%

Performance & Financial Health Analysis: Kwality Pharmaceuticals Ltd. vs Innova Captab Ltd.

MetricKPLINNOVACAP
Market Information
Market Cap i₹17.47B₹41.43B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i28,897578,151
90 Day Avg. Volume i30,328217,693
Last Close₹2,344.90₹857.00
52 Week Range₹828.80 - ₹2,389.70₹622.00 - ₹1,020.70
% from 52W High-1.87%-16.04%
All-Time High₹2,389.70 (Jun 01, 2026)₹1,260.00 (Jan 06, 2025)
% from All-Time High-1.87%-31.98%
Growth Metrics
Quarterly Revenue Growth0.46%0.42%
Quarterly Earnings Growth0.88%0.23%
Financial Health
Profit Margin (TTM) i0.12%0.09%
Operating Margin (TTM) i0.21%0.13%
Return on Equity (TTM) i0.15%0.13%
Debt to Equity (MRQ) i38.2932.95
Cash & Liquidity
Book Value per Share (MRQ)₹279.50₹178.28
Cash per Share (MRQ)₹32.82₹10.22
Operating Cash Flow (TTM) i₹387.34M₹282.88M
Levered Free Cash Flow (TTM) i₹398.45M₹1.28B
Dividends
Last 12-Month Dividend Yield iN/A0.30%
Last 12-Month Dividend i₹0.00₹2.00

Valuation & Enterprise Metrics Analysis: Kwality Pharmaceuticals Ltd. vs Innova Captab Ltd.

MetricKPL (Apr 24, 2026)INNOVACAP (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i30.8631.20
Forward P/E iN/A21.90
PEG Ratio i0.351.33
Price to Sales (TTM) i3.782.76
Price to Book (MRQ) i6.024.05
Market Capitalization
Market Capitalization i₹17.47B₹41.43B
Enterprise Value i₹18.21B₹43.41B
Enterprise Value Metrics
Enterprise to Revenue i3.952.90
Enterprise to EBITDA i17.2820.49
Risk & Other Metrics
Beta i0.13-0.33
Book Value per Share (MRQ) i₹279.50₹178.28

Financial Statements Comparison: Kwality Pharmaceuticals Ltd. vs Innova Captab Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricKPL (2025)INNOVACAP (2025)
Revenue/Sales i3.70B12.34B
Cost of Goods Sold i1.87B8.38B
COGS % of Revenue i50.6%67.9%
Gross Profit i1.83B3.96B
Gross Margin i49.4%32.1%
Research & Development iN/AN/A
Operating Income (EBIT) i620.98M1.65B
Operating Margin i16.8%13.4%
EBITDA i822.79M2.00B
EBITDA Margin i22.2%16.2%
Pre-Tax Income i541.40M1.71B
Pre-Tax Income % of Revenue i14.6%13.9%
Income Tax i143.37M427.58M
Income Tax % of Revenue i3.9%3.5%
Net Income (Profit) i398.03M1.28B
Profit Margin i10.8%10.4%

Balance Sheet & Liquidity Metrics

MetricKPL (2025)INNOVACAP (2025)
Cash & Equivalents i120.20M155.19M
Total Current Assets i2.84B7.03B
Total Current Assets % of Revenue i76.7%57.0%
Total Current Liabilities i1.70B3.53B
Total Current Liabilities % of Revenue i45.8%28.6%
Long-Term Debt i151.19M2.45B
Long-Term Debt % of Revenue i4.1%19.8%
Total Shareholders Equity i2.62B9.59B
Retained Earnings i2.44B4.53B
Retained Earnings % of Revenue i66.0%36.7%
Property, Plant & Equipment i458.28M442.93M

Cash Flow Statement Comparison

MetricKPL (2025)INNOVACAP (2025)
Operating Cash Flow i387.34M282.88M
Operating Cash Flow % of Revenue i10.5%2.3%
Capital Expenditures i-232.17M-1.72B
Free Cash Flow i277.15M-1.09B
FCF Margin i7.5%-8.8%
Debt Repayment i-133.57M-114.03M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricKPLINNOVACAP
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i10.38M57.22M
Float Shares i2.30M15.91M
% Held by Insiders i103.85%72.19%
% Held by Institutions i0.00%19.22%
% Held by Public i-3.85%8.59%

Dividend Analysis & Yield Comparison: Kwality Pharmaceuticals Ltd. vs Innova Captab Ltd.

MetricKPLINNOVACAP
Last 12-Month Dividend i₹0.00₹2.00
Last 12-Month Dividend Yield iN/A0.30%
3-Year Avg Annual Dividend i₹0.00₹0.67
3-Year Avg Dividend Yield iN/A0.30%
3-Year Total Dividends i₹0.00₹2.00
Ex-Dividend DateN/AJan 30, 2026